IQVIA HOLDINGS INC. Increase (Decrease) in Contract with Customer, Liability
IQVIA HOLDINGS INC. (IQV) reported Increase (Decrease) in Contract with Customer, Liability of $143.00 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2026-05-05
- IQVIA HOLDINGS INC. increase (decrease) in contract with customer, liability for the quarter ending 2026-03-31 was $143.00M, a 11.18% decline year-over-year.
- IQVIA HOLDINGS INC. increase (decrease) in contract with customer, liability for the quarter ending 2025-12-31 was -$42.00M.
- IQVIA HOLDINGS INC. increase (decrease) in contract with customer, liability for the quarter ending 2025-09-30 was $37.00M, a 184.62% increase year-over-year.
- IQVIA HOLDINGS INC. increase (decrease) in contract with customer, liability for the quarter ending 2025-06-30 was $183.00M.
- IQVIA HOLDINGS INC. increase (decrease) in contract with customer, liability for fiscal 2025 was $339.00M.
- IQVIA HOLDINGS INC. increase (decrease) in contract with customer, liability for fiscal 2024 was -$20.00M, a 1100.00% decline from fiscal 2023.
- IQVIA HOLDINGS INC. increase (decrease) in contract with customer, liability for fiscal 2023 was $2.00M.
- IQVIA HOLDINGS INC. increase (decrease) in contract with customer, liability for fiscal 2022 was -$28.00M, a 104.89% decline from fiscal 2021.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|
| 2026-03-31 | $143.00M 10-Q · filed 2026-05-05 | $101.00M derived: sum of 2 quarters · filed 2026-05-05 | $138.00M derived: sum of 3 quarters · filed 2026-05-05 | $321.00M derived: sum of 4 quarters · filed 2026-05-05 |
| 2025-12-31 | -$42.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | -$5.00M derived: sum of 2 quarters · filed 2026-02-17 | $178.00M derived: sum of 3 quarters · filed 2026-02-17 | $339.00M 10-K · filed 2026-02-17 |
| 2025-09-30 | $37.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $220.00M derived: sum of 2 quarters · filed 2025-10-28 | $381.00M 10-Q · filed 2025-10-28 | $336.00M derived: sum of 4 quarters · filed 2025-10-28 |
| 2025-06-30 | $183.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-22 | $344.00M 10-Q · filed 2025-07-22 | $299.00M derived: sum of 3 quarters · filed 2025-07-22 | $312.00M derived: sum of 4 quarters · filed 2025-07-22 |
| 2025-03-31 | $161.00M 10-Q · filed 2025-05-06 | $116.00M derived: sum of 2 quarters · filed 2025-05-06 | $129.00M derived: sum of 3 quarters · filed 2025-05-06 | $26.00M derived: sum of 4 quarters · filed 2025-05-06 |
| 2024-12-31 | -$45.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | -$32.00M derived: sum of 2 quarters · filed 2025-02-13 | -$135.00M derived: sum of 3 quarters · filed 2025-02-13 | -$20.00M 10-K · filed 2025-02-13 |
| 2024-09-30 | $13.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | -$90.00M derived: sum of 2 quarters · filed 2024-10-31 | $25.00M 10-Q · filed 2024-10-31 | -$14.00M derived: sum of 4 quarters · filed 2024-10-31 |
| 2024-06-30 | -$103.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-22 | $12.00M 10-Q · filed 2024-07-22 | -$27.00M derived: sum of 3 quarters · filed 2024-07-22 | -$33.00M derived: sum of 4 quarters · filed 2024-07-22 |
| 2024-03-31 | $115.00M 10-Q · filed 2024-05-02 | $76.00M derived: sum of 2 quarters · filed 2024-05-02 | $70.00M derived: sum of 3 quarters · filed 2024-05-02 | $87.00M derived: sum of 4 quarters · filed 2024-05-02 |
| 2023-12-31 | -$39.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | -$45.00M derived: sum of 2 quarters · filed 2024-02-15 | -$28.00M derived: sum of 3 quarters · filed 2024-02-15 | $2.00M 10-K · filed 2024-02-15 |
| 2023-09-30 | -$6.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $11.00M derived: sum of 2 quarters · filed 2023-11-01 | $41.00M 10-Q · filed 2023-11-01 | -$4.00M derived: sum of 4 quarters · filed 2023-11-01 |
| 2023-06-30 | $17.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $47.00M 10-Q · filed 2023-08-01 | $2.00M derived: sum of 3 quarters · filed 2023-08-01 | $34.00M derived: sum of 4 quarters · filed 2023-08-01 |
| 2023-03-31 | $30.00M 10-Q · filed 2023-04-28 | -$15.00M derived: sum of 2 quarters · filed 2023-04-28 | $17.00M derived: sum of 3 quarters · filed 2023-04-28 | -$100.00M derived: sum of 4 quarters · filed 2023-04-28 |
| 2022-12-31 | -$45.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15 | -$13.00M derived: sum of 2 quarters · filed 2023-02-15 | -$130.00M derived: sum of 3 quarters · filed 2023-02-15 | -$28.00M 10-K · filed 2023-02-15 |
| 2022-09-30 | $32.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | -$85.00M derived: sum of 2 quarters · filed 2022-10-27 | $17.00M 10-Q · filed 2022-10-27 | $16.00M derived: sum of 4 quarters · filed 2022-10-27 |
| 2022-06-30 | -$117.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-22 | -$15.00M 10-Q · filed 2022-07-22 | -$16.00M derived: sum of 3 quarters · filed 2022-07-22 | $213.00M derived: sum of 4 quarters · filed 2022-07-22 |
| 2022-03-31 | $102.00M 10-Q · filed 2022-04-28 | $101.00M derived: sum of 2 quarters · filed 2022-04-28 | $330.00M derived: sum of 3 quarters · filed 2022-04-28 | $373.00M derived: sum of 4 quarters · filed 2022-04-28 |
| 2021-12-31 | -$1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $228.00M derived: sum of 2 quarters · filed 2022-02-16 | $271.00M derived: sum of 3 quarters · filed 2022-02-16 | $573.00M 10-K · filed 2022-02-16 |
| 2021-09-30 | $229.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-22 | $272.00M derived: sum of 2 quarters · filed 2021-10-22 | $574.00M 10-Q · filed 2021-10-22 | $638.00M derived: sum of 4 quarters · filed 2021-10-22 |
| 2021-06-30 | $43.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28 | $345.00M 10-Q · filed 2021-07-28 | $409.00M derived: sum of 3 quarters · filed 2021-07-28 | $536.00M derived: sum of 4 quarters · filed 2021-07-28 |
| 2021-03-31 | $302.00M 10-Q · filed 2021-04-23 | $366.00M derived: sum of 2 quarters · filed 2021-04-23 | $493.00M derived: sum of 3 quarters · filed 2021-04-23 | $518.00M derived: sum of 4 quarters · filed 2021-04-23 |
| 2020-12-31 | $64.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $191.00M derived: sum of 2 quarters · filed 2021-02-12 | $216.00M derived: sum of 3 quarters · filed 2021-02-12 | $238.00M 10-K · filed 2021-02-12 |
| 2020-09-30 | $127.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-22 | $152.00M derived: sum of 2 quarters · filed 2020-10-22 | $174.00M 10-Q · filed 2020-10-22 | $128.00M derived: sum of 4 quarters · filed 2020-10-22 |
| 2020-06-30 | $25.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-23 | $47.00M 10-Q · filed 2020-07-23 | $1.00M derived: sum of 3 quarters · filed 2020-07-23 | -$19.00M derived: sum of 4 quarters · filed 2020-07-23 |
| 2020-03-31 | $22.00M 10-Q · filed 2020-04-30 | -$24.00M derived: sum of 2 quarters · filed 2020-04-30 | -$44.00M derived: sum of 3 quarters · filed 2020-04-30 | -$7.00M derived: sum of 4 quarters · filed 2020-04-30 |
| 2019-12-31 | -$46.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18 | -$66.00M derived: sum of 2 quarters · filed 2020-02-18 | -$29.00M derived: sum of 3 quarters · filed 2020-02-18 | $7.00M 10-K · filed 2020-02-18 |
| 2019-09-30 | -$20.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-01 | $17.00M derived: sum of 2 quarters · filed 2019-11-01 | $53.00M 10-Q · filed 2019-11-01 | |
| 2019-06-30 | $37.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24 | $73.00M 10-Q · filed 2019-07-24 | ||
| 2019-03-31 | $36.00M 10-Q · filed 2019-05-02 | |||
| 2018-12-31 | $22.00M 10-K · filed 2019-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |